tailieunhanh - Comparative evaluation of somatostatin and CXCR4 receptor expression in diferent types of thyroid carcinoma using well-characterised monoclonal antibodies

Papillary and follicular thyroid carcinomas can be treated surgically and with radioiodine therapy, whereas therapeutic options for advanced stage IV medullary and for anaplastic tumours are limited. Recently, somatostatin receptors (SSTs) and the chemokine receptor CXCR4 have been evaluated for the treatment of thyroid carcinomas, however, with contradictory results. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN